Telehealth monitoring for hypertrophic cardiomyopathy and amyloid cardiomyopathy patients: lessons from the coronavirus disease 2019 lockdown in Italy
J Cardiovasc Med (Hagerstown)
.
2020 Aug;21(8):622-623.
doi: 10.2459/JCM.0000000000001024.
Authors
Giacomo Tini
1
2
,
Pier F Vianello
1
,
Ginevra Rizzola
1
2
,
Giovanni La Malfa
1
2
,
Italo Porto
1
2
,
Marco Canepa
1
2
Affiliations
1
Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, IRCCS Italian Cardiovascular Network.
2
Department of Internal Medicine, University of Genova, Genova, Italy.
PMID:
32628425
DOI:
10.2459/JCM.0000000000001024
No abstract available
MeSH terms
Adult
Aged
Aged, 80 and over
Amyloidosis*
COVID-19
Cardiomyopathy, Hypertrophic*
Coronavirus Infections*
Disease Management*
Female
Humans
Italy
Male
Middle Aged
Pandemics*
Pneumonia, Viral*
Telemedicine*
Young Adult